RAC 0.50% $2.02 race oncology ltd

Industry news, page-1508

  1. 847 Posts.
    lightbulb Created with Sketch. 1036
    Wondering if anyone has read this book "For Blood and Money", which details the story of Pharmacyclics—which developed the drug ibrutinib, a treatment for chronic lymphocytic leukemia—which was eventually bought by the pharmaceutical giant AbbVie in 2015 for $21USD billion

    I've just come it and looks a very interesting & topical read, so have just ordered it.


    https://hotcopper.com.au/data/attachments/5771/5771207-eeb34de689cd81d13a83ef9ac60c21f4.jpg

    Review here https://www.nybooks.com/articles/2023/05/25/saving-lives-and-making-a-killing-for-blood-and-money-vardi/#:~:text=In%20For%20Blood%20and%20Money,success%20in%20the%20biotechnology%20industry.

    Further info about ibrutinib here https://en.wikipedia.org/wiki/Ibrutinib

    And some insights from the author Nathan Vardi which sound familiar Dr.T @Davisite
    https://nextbigideaclub.com/magazine/blood-money-billionaires-biotech-quest-blockbuster-drug-bookbite/39693/

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$2.02
Change
0.010(0.50%)
Mkt cap ! $343.9M
Open High Low Value Volume
$2.04 $2.09 $1.92 $768.4K 380.3K

Buyers (Bids)

No. Vol. Price($)
1 484 $2.00
 

Sellers (Offers)

Price($) Vol. No.
$2.02 3251 2
View Market Depth
Last trade - 16.10pm 19/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.